The Role of Circadian Factors in Regulation of Neuroplasticity in Ischemic Stroke (Observational)

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-80
SponsorFederal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health

About this trial

The study is aimed at the investigation of the association of biomarkers of circadian rhythms with sleep characteristics and stroke outcome in acute stroke patients. It is designed as an observational cohort study with the retrospective and prospective longitudinal arms.

Eligibility criteria

Qualifiers

acute (symptom onset to admission <1 days) ischemic stroke

ischemic stroke affecting the branches of anterior cerebral artery, middle cerebral artery and posterior cerebral artery

age 18-80 years

moderate or severe stroke (National Institutes of Health Stroke Scale, NIHSS>=5)

Disqualifiers

secondary parenchymal hemorrhage (>hemorrhage index -2)

clinically unstable or life-threatening conditions

known progressive neurological diseases

known psychiatric diseases

Trial design

Treatments tested in this trial

  • No intervention is planned

Treatment groups

250 Participants
are divided into 2 treatment groups